InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,172.40
(
1.13%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.14
(
-1.33%
)
Bitcoin
61,851.17
(
2.64%
)
Post# of 203990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

AMA1

Send PM Follow Ignore
Followers 0
Posts 331
Boards Moderated 0
Alias Born 04/04/2005

AMA1

Re: lsd673 post# 197333

Friday, 07/31/2009 9:46:22 AM

Friday, July 31, 2009 9:46:22 AM

Post# of 203990
Pfizer or Bristol-Myers should buy Xechem out. $0.25 per share (about $875 million) is a steal for a product with over a $1 billion market. They may also find other uses for Nicosan. Instead, they are both trying to develop their own drug for SCD and they are failing at it.

Monty, have you tried talking to these guys? This is our best case scenario. I think.


Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up